Literature DB >> 31549332

Congenital Portosystemic Shunts in Children: Associations, Complications, and Outcomes.

Frank DiPaola1, Andrew T Trout2,3, Ashley E Walther4, Anita Gupta5, Rachel Sheridan5, Kathleen M Campbell6, Greg Tiao7, Jorge A Bezerra6, Kevin E Bove5, Manish Patel2,3, Jaimie D Nathan7.   

Abstract

BACKGROUND: Congenital portosystemic shunt (CPSS) is a rare malformation in which splanchnic venous flow bypasses the liver. CPSS is associated with other congenital anomalies and syndromes and can be associated with life-threatening complications. CPSS and their management remain underreported in the literature. Here, we review the clinical characteristics, management, and outcomes of a cohort of children and young adults with CPSS from two pediatric centers.
METHODS: Cases of CPSS from Cincinnati Children's Hospital Medical Center and C.S. Mott Children's Hospital were reviewed to define CPSS anatomy, associated anomalies, complications, interventions, and outcomes. The imaging features and histopathology of liver lesions were characterized in detail.
RESULTS: A total of 11 cases were identified. Median age was 10 years (range 0-26); 8 (73%) cases were female. Associated anomalies included six patients with heterotaxy (55%), five patients with congenital heart disease (45%), three patients with Turner syndrome (27%), and two patients with omphalocele, exstrophy, imperforate anus, spinal defects (OEIS) complex (18%). Eight (73%) cases had hyperammonemia ± encephalopathy. A 4-month-old presented with hepatopulmonary syndrome, and 12-year-old presented with pulmonary hypertension. Eight patients (73%) had liver lesions including five with premalignant adenomas and three with well-differentiated hepatocellular carcinoma (HCC). Four children underwent successful CPSS occlusion/ligation. Three children underwent liver transplant (2) or resection (1) for HCC without recurrence at extended follow-up.
CONCLUSIONS: CPSS is associated with multiple anomalies (heterotaxy, congenital heart disease) and syndromes (Turner syndrome). CPSS liver lesions should be very carefully evaluated due to risk of premalignant adenomas and HCC. Serious complications of CPSS can occur at a young age but can be managed endovascularly or with open surgery.

Entities:  

Keywords:  Abernethy; Hepatocellular adenoma; Hepatocellular carcinoma; Liver; Portosystemic shunt

Mesh:

Year:  2019        PMID: 31549332      PMCID: PMC8180198          DOI: 10.1007/s10620-019-05834-w

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  47 in total

1.  Balloon-occluded retrograde transvenous obliteration for congenital portosystemic venous shunt: report of two cases.

Authors:  Hazumu Nagata; Kenichiro Yamamura; Kazuyuki Ikeda; Kenji Ihara; Toshiro Hara
Journal:  Pediatr Int       Date:  2012-06       Impact factor: 1.524

2.  Congenital absence of the portal vein in a child with Turner syndrome.

Authors:  Jacob A Noe; Heather C Pittman; Edward M Burton
Journal:  Pediatr Radiol       Date:  2006-04-13

3.  Blood flow and oxygen consumption rates of human gynecological tumors xenografted into rnu/rnu-rats.

Authors:  P Vaupel; F Kallinowski; S Runkel; K Schlenger; H P Fortmeyer
Journal:  Strahlenther Onkol       Date:  1989-07       Impact factor: 3.621

Review 4.  Congenital portosystemic shunt: characterization of a multisystem disease.

Authors:  Christiane Sokollik; Robert H J Bandsma; Juan C Gana; Meta van den Heuvel; Simon C Ling
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-06       Impact factor: 2.839

Review 5.  Congenital extrahepatic portocaval shunts--the Abernethy malformation.

Authors:  E R Howard; M Davenport
Journal:  J Pediatr Surg       Date:  1997-03       Impact factor: 2.545

6.  Complications of congenital portosystemic shunts in children: therapeutic options and outcomes.

Authors:  Stéphanie Franchi-Abella; Sophie Branchereau; Virginie Lambert; Monique Fabre; Clarisa Steimberg; Jean Losay; Jean-Yves Riou; Danièle Pariente; Frédéric Gauthier; Emmanuel Jacquemin; Olivier Bernard
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-09       Impact factor: 2.839

7.  Regression of pulmonary vascular disease after therapy of Abernethy malformation in visceral heterotaxy.

Authors:  Krishnan A Raghuram; Sasidharan Bijulal; Kavasseri M Krishnamoorthy; Jaganmohan A Tharakan
Journal:  Pediatr Cardiol       Date:  2012-07-28       Impact factor: 1.655

8.  Abnormalities of the umbilico-portal venous system in Down syndrome: a report of two new patients.

Authors:  Salvatore Pipitone; Caterina Garofalo; Giovanni Corsello; Maurizio Mongiovì; Maria Piccione; Emiliano Maresi; Velio Sperandeo
Journal:  Am J Med Genet A       Date:  2003-08-01       Impact factor: 2.802

9.  Glypican-3 as a useful diagnostic marker that distinguishes hepatocellular carcinoma from benign hepatocellular mass lesions.

Authors:  Hanlin L Wang; Florencia Anatelli; Qihui Jim Zhai; Brian Adley; Shang-Tian Chuang; Ximing J Yang
Journal:  Arch Pathol Lab Med       Date:  2008-11       Impact factor: 5.534

Review 10.  Congenital extrahepatic portosystemic shunt complicated by the development of hepatocellular carcinoma.

Authors:  Ruchi Sharma; Abid Suddle; Alberto Quaglia; Praveen Peddu; John Karani; Thomas Satyadas; Nigel Heaton
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2015-10
View more
  6 in total

1.  Case Report: Membranoproliferative Glomerulonephritis, a Rare Clinical Manifestation of Abernethy Malformation Type II.

Authors:  Xue He; Yueling Zhu; Haidong Fu; Chunyue Feng; Zhixia Liu; Weizhong Gu; Yanyan Jin; Binbin Yang; Huijun Shen
Journal:  Front Pediatr       Date:  2021-03-17       Impact factor: 3.418

Review 2.  Presentation of Congenital Portosystemic Shunts in Children.

Authors:  Atessa Bahadori; Beatrice Kuhlmann; Dominique Debray; Stephanie Franchi-Abella; Julie Wacker; Maurice Beghetti; Barbara E Wildhaber; Valérie Anne McLin
Journal:  Children (Basel)       Date:  2022-02-11

Review 3.  Clinical Developmental Cardiology for Understanding Etiology of Congenital Heart Disease.

Authors:  Hiroyuki Yamagishi
Journal:  J Clin Med       Date:  2022-04-24       Impact factor: 4.241

4.  Progress of pulmonary hypertension and high manganese levels through congenital portosystemic shunt closure.

Authors:  Toshihiko Kakiuchi; Yuta Baba; Nobuya Minematsu; Hirohito Doi; Takashi Kumamoto
Journal:  Clin Case Rep       Date:  2022-09-12

Review 5.  Rare Inherited Cholestatic Disorders and Molecular Links to Hepatocarcinogenesis.

Authors:  Rebecca Jeyaraj; Deirdre Kelly
Journal:  Cells       Date:  2022-08-18       Impact factor: 7.666

6.  Case report: Rare abernethy malformation with hepatopulmonary syndrome in a pediatric patient.

Authors:  Lianfu Ji; Zhaoming Ji; Dandan Xiang; Yuming Qin; Shiwei Yang
Journal:  Front Pediatr       Date:  2022-09-09       Impact factor: 3.569

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.